Skip to content
Back to the blogGuides

Do Peptides Need to Be Refrigerated?

Avery Lund8 min read

Yes, for the refrigerator part — every FDA-approved GLP-1 product checked for this article agrees that it should be stored refrigerated at 2°C to 8°C (36°F to 46°F) before first use. What they don't agree on is how long the product is good for once it's out of the refrigerator: that ranges from 21 days to 56 days depending on the exact product, and even depending on which version of that product you have. The part people assume is universal — the fridge — is the part that's consistent. The part people assume is minor — the countdown once it's out — is the part that actually varies.

This article reports what FDA-approved product labels say, pulled directly from DailyMed. It is not medical advice and it does not apply to research peptides, compounded preparations, or anything without its own approved label — see the section on that below.

Do peptides need to be refrigerated?

For the three FDA-approved products checked here, the label answer is consistent before first use. The Ozempic label states: “Prior to first use, the OZEMPIC pen should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F).” The Mounjaro label says to “store MOUNJARO single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F).” The Zepbound label matches: “Store in a refrigerator at 2°C to 8°C (36°F to 46°F).”

Same range, three different products. That consistency is exactly why the next question matters more — because it's where the agreement stops.

How long do peptides last at room temperature?

This is where the three labels diverge, and where reading the actual number for your specific product matters. The Ozempic label gives two different answers depending on the device: for the pen, “the pen can be stored for 56 days at controlled room temperature 15°C to 30°C (59°F to 86°F) or in a refrigerator 2°C to 8°C (36°F to 46°F)” after first use. For the prefilled syringe, “if needed, the syringe can be kept from 8°C to 30°C (46°F to 86°F) up to 28 days.” Same molecule, same brand, two different allowances depending on which device it comes in.

Mounjaro's label allows less time: “if needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days.” Its multi-dose vial and KwikPen have a separate rule — “throw away opened multi-dose vial or single-patient-use KwikPen after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses.”

Zepbound's label lands at the same 21-day figure as Mounjaro's single-dose version: “ZEPBOUND may be stored at room temperature up to 30°C (86°F) for up to 21 days.” Mounjaro and Zepbound both contain tirzepatide, so it might seem like the number should carry over between them — and here it happens to match. But that's not something to assume going in. Ozempic's own pen and syringe, two presentations of the same drug, don't match each other (56 days vs. 28 days). The number comes from stability testing done on that specific product and packaging, not from the molecule alone.

Refrigeration and room-temperature allowance, by product

ProductRefrigerated rangeTime allowed out of the fridge
Ozempic pen2°C–8°C (36°F–46°F)56 days at 15°C–30°C (59°F–86°F), after first use
Ozempic prefilled syringe2°C–8°C (36°F–46°F)28 days at 8°C–30°C (46°F–86°F)
Mounjaro single-dose pen / vial2°C–8°C (36°F–46°F)21 days, not to exceed 30°C (86°F)
Mounjaro multi-dose vial / KwikPen2°C–8°C (36°F–46°F)Discard after a total of 30 days at room temperature, 30 days after first use, or after 4 weekly doses
Zepbound2°C–8°C (36°F–46°F)21 days, not to exceed 30°C (86°F)

Figures pulled directly from each product's DailyMed label (linked above and below), as of August 2026. Labels are revised from time to time, so check the current label for your product. These numbers apply only to the exact product and presentation listed — not to other products, other packaging of the same product, or anything without its own label.

Can peptides be frozen?

No, according to all three labels checked here. Ozempic's label states: “Do not freeze OZEMPIC and do not use OZEMPIC if it has been frozen,” and separately warns “do not store in the freezer or directly adjacent to the refrigerator cooling element.” Mounjaro's label says: “Do not freeze MOUNJARO. Do not use MOUNJARO if frozen.” Zepbound's label says the same: “Do not freeze. Do not use ZEPBOUND if it has been frozen.”

All three labels also call out light exposure separately from temperature. Ozempic: “Protect OZEMPIC from light” and “OZEMPIC must be kept in the original carton until time of administration.” Mounjaro: “Store MOUNJARO in the original carton to protect from light.” Zepbound: “Keep ZEPBOUND in the original carton in order to protect from light.” Freezing and light exposure are treated as separate failure modes from the temperature range itself, worth tracking on their own.

What about research peptides or compounded preparations?

Everything above applies to FDA-approved, commercially manufactured products with an approved label. A research peptide, a grey-market vial, or a compounded preparation has no such label, and its storage requirements aren't knowable from the numbers on this page. Ozempic's 56 days, Mounjaro's 21 days, and Zepbound's 21 days are specific to those exact FDA-approved products — they don't transfer to a different product, a different concentration, or a compounded version, even one containing a similar or identical peptide.

For a compounded preparation, the relevant framework is the beyond-use date, or BUD. USP's BUD factsheet defines it plainly: “Beyond-use dates (BUDs) are the date or time after which a compounded sterile preparation (CSP) or compounded nonsterile preparation (CNSP) may not be stored or transported and are calculated from the date or time of compounding,” and the BUD “serves to alert healthcare workers to the time/day after which a CSP or CNSP must not be used.” The applicable standard, USP General Chapter <797>, covers sterile compounding and became official November 1, 2023.

In practice, that means: for anything compounded or unlabeled, the storage window and BUD come from the compounding pharmacy or prescriber who dispensed it — not from a general article, and not by borrowing a number from Ozempic, Mounjaro, or Zepbound because the active ingredient sounds similar. Ask whoever dispensed it what applies to your specific vial.

What actually matters day to day

Whichever category a product falls into, the same practical fact holds: a room-temperature allowance is a countdown that starts on a specific day, either “first use” on an FDA label or the compounding date on a BUD. The label or the pharmacy gives you the number of days. Something still has to remember which day the clock started.

That's a narrower problem than storage rules themselves, and it's the part keeping a written record of your stack is good for. StackLogR lets you log a vial's open date alongside your doses, so “how many days has this been out” is a lookup instead of a guess. It doesn't know or set the storage rule for any given product — that still comes from the label or the pharmacy — it just keeps track of the date you'd otherwise have to remember yourself.

FAQ

Do peptides need to be refrigerated?

For FDA-approved products like Ozempic, Mounjaro, and Zepbound, yes — the label says to store them refrigerated at 2°C to 8°C (36°F to 46°F) before first use. What varies by product is how long they can come out of the refrigerator afterward. There is no single answer that covers every peptide; check the specific product's label.

How do I store peptides?

For an FDA-approved product, the label on the carton tells you exactly how, including the refrigerated range and how long it can sit at room temperature. For a research peptide, compounded preparation, or anything without an approved label, that information isn't publicly knowable the same way — it comes from whoever dispensed it.

How long do peptides last at room temperature?

It depends entirely on the specific product. Ozempic's pen allows 56 days at room temperature after first use, while its prefilled syringe allows 28 days. Mounjaro and Zepbound both allow 21 days. These numbers come from each product's own FDA label and don't transfer to other products, even ones with the same active ingredient.

How do I store peptides after reconstitution?

This article covers storage, not how to reconstitute anything — no mixing instructions here. Once a product is in use, the same label that gives the refrigerator range also gives the countdown for how long it's good for. For anything compounded or unlabeled, that countdown comes from the pharmacy or prescriber who dispensed it, not from a general rule.

Can peptides be frozen?

No, not according to any of the labels checked for this article. Ozempic, Mounjaro, and Zepbound labels all explicitly say not to freeze and not to use the product if it has been frozen.

Does it matter if a peptide pen or vial is left out of the light?

Yes — the Ozempic, Mounjaro, and Zepbound labels all instruct keeping the product in its original carton to protect it from light, separate from the temperature question.

Why do two versions of the same product have different room-temperature limits?

Ozempic is the clearest example: its pen allows 56 days at room temperature after first use, while its prefilled syringe allows 28 days. Same brand, same molecule, two different numbers. Stability testing is done per product and per presentation (pen vs. syringe vs. vial), so the packaging matters, not just the active ingredient. Mounjaro and Zepbound both contain tirzepatide and both happen to allow 21 days, but a match like that isn't something to assume in advance.

Where do I find storage rules for a research peptide or a compounded vial?

Not from a general article. Research peptides and compounded preparations don't carry FDA-approved labels, so there's no public source with a stability number the way there is for Ozempic or Zepbound. For a compounded product, the relevant framework is USP's beyond-use date system, and the actual number comes from the compounding pharmacy or prescriber who made or dispensed it.


This article is for informational purposes only and isn't medical advice. It reports storage instructions published on FDA-approved product labels via DailyMed as of the date written, plus the general USP beyond-use date framework for compounded preparations — it does not tell you how to reconstitute anything, and it does not extend any product's numbers to a different product, a different presentation, or an unlabeled compound. StackLogR is a record-keeping tool, not a source of storage rules or medical advice. Always follow the storage instructions on your product's actual label, or the instructions given by your compounding pharmacy or prescriber, and check the label or packaging directly rather than relying on any secondary source, including this one.

Try the app this post keeps mentioning.

StackLogR is free, on-device, and built for exactly this.

Avery Lund writes about tracking, logging, and the unglamorous logistics of staying consistent. Not a clinician; nothing here is medical advice.

StackLogR is for tracking and education only. It does not provide dosing or medical advice.